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Summary
Calnexin is a resident protein of the endoplasmic reticulum (ER) that associates with nascent
protein chains. Among the newly synthesized integral membrane proteins known to bind to
calnexin is invariant chain (Ii), and Ii release from calnexin coincides with proper assembly
with major histocompatibility complex (MHC) class 11 heterodimers. Although calnexin asso-
ciation with several membrane glycoproteins depends on interactions involving N-linked
glycans, we previously reported that a truncation mutant of mouse Ii (mlil-107) lacking both
N-glycosylation sites was highly effective in associating with MHC class II heterodimers and
escorting these dimers through the secretory pathway. This could indicate that calnexin, de-
spite binding to both Ii and class 11, is not necessary for the proper interaction of these proteins,
or that in contrast to most membrane glycoproteins, the N-linked glycans of Ii are not critical
to its interaction with this chaperone. To examine this issue, we have directly explored the
binding of calnexin to both Ii truncation mutants lacking the typical sites ofN-glycosylation or
Ii produced in cells treated with tunicamycin to prevent glycan addition. These experiments
revealed that either method ofeliminating N-linked carbohydrates on Ii also inhibited associa-
tion with calnexin. A lumenally truncated form of Ii (mlil-131) that still has N-linked carbo-
hydrates showed a decreased affinity for calnexin compared with intact Ii, however, indicating
that calnexin-Ii binding is not determined solely by the sugar moieties. All forms of Ii lacking
N-linked sugars and showing defective association with calnexin also had enhanced rates of
preendosomal degradation. Despite this effect on degradation rate, tunicamycin treatment did
not inhibit the association of class II with glycan-free Ii. These data support the view that cal-
nexin is not an absolute requirement for the proper assembly ofclass II-Ii nonamers, but rather
acts primarily to retain Ii in the ER and to inhibit its degradation. These two properties of cal-
nexin-Ii interaction may help ensure that sufficient intact Ii is available for efficient inactivation
ofthe binding sites of newly synthesized class 11 molecules, while limiting the ability of excess
free Ii to alter the transport properties of the early endocytic pathway.
I
nvariant chain (Ii)' is a type 11 integral membrane glyco-
protein that associates with newly synthesized MHC
class II chains shortly after their import into the endoplas-
mic reticulum (ER). Ii forms noncovalent homotrimers (1),
each chain ofwhich associates with a class 11 up heterodimer
(2). This nonameric structure is competent for movement
out of the ER and through the Golgi complex and trans-
Golgi network. By either a direct route (3-5) or through a
pathway involving the plasma membrane and early endo-
somes (5-9), the complex moves to more acidic and pro-
teolytic endocytic organelles where Ii is degraded and pep-
tide ligands are acquired by the class II molecules (9-14).
'Abbreviations used in this paper: DSP, dithiobis[succinylproprionate] ; ER, en-
doplasmic reticulum; li, invariant chain; mIi, mouse Ii.
Several different experimental models have been used to
explore the events involved in the initial assembly and in-
tracellular trafficking of class 11 heterodimers and Ii, as well
as the fate of subsets of these chains produced in the ab-
sence of one or more of the oligomer subunits. Results ob-
tained from studies in microsome-containing in vitro trans-
lation systems (15-17), after transient (18-20) and stable
(21) transfection of various fibroblast cell lines and using
lymphoid cells from mice whose Ii genes have been dis-
rupted by homologous recombination (22-24), all indicate
that class II heterodimers can be formed in the absence of
Ii. The extent to which heterodimer assembly occurs in the
absence of Ii, however, varies greatly among allelic class 11
products (20, 25) . In addition, cells producing class II ot and
R chains in the absence of Ii show elevated levels of class II
2027
￿
J. Exp. Med. © The Rockefeller University Press " 0022-1007/95/12/2027/10 $2.00
Volume 182 December 1995 2027-2036proteins in high molecular weight complexes (26), and
similar aggregates are seen in normal lymphoid cells at very
short times after protein entry into the ER (27) . In normal
cells with Ii, these class II chains rapidly leave such aggre-
gates and assemble into typical nonameric complexes with
Ii. In the absence of Ii, the class II chains largely remain in
aggregates, before degradation. This aggregation-prone be-
havior ofclass II is also seen with heterodimers produced in
insect cells in the absence of 1i (28) and with class 11 het-
erodimers removed from nonameric complexes with Ii us-
ing low pH (29) . In each of these circumstances, aggrega-
tion can be prevented by substituting an antigenic peptide
for Ii. This suggests either a special role for binding site
occupancy in folding class II so as to avoid nonspecific
protein-protein interactions, or direct recognition by the
binding site of target structures present on non-MHC pro-
tein aggregates.
In both transfected cells (20, 21) and lymphocytes of Ii-
deficient mice (22-24), the cohort of class 11 heterodimers
that does form in the absence of Ii shows defective trans-
port from the ER to the Golgi complex. This is character-
istically seen as the failure of the ot and (3 chains in these
serologically normal heterodimers to acquire endoglycosi-
dase-resistant N-linked glycans, even at late times after syn-
thesis . This transport deficiency can be ascribed to any of
several events. One is the aggregation phenomenon, as
even a(3 heterodimers are associated with very high molec-
ular complexes of incompletely assembled class II chains
under some circumstances. However, Ii produced in the
absence of class II also shows delayed exit from the ER
(30), yet fails to demonstrate the aggregation typical of class
II (26, 27). Another possible mechanism is the association
of both Ii and class II chains with the ER-resident protein
calnexin (p88, IP90) (31, 32), an interaction that is lost effi-
ciently only upon completion of nonamer assembly.
Calnexin is an integral membrane protein of high abun-
dance in the ER that associates with a large number of
newly synthesized membrane-bound and soluble proteins
(for reviews see references 33, 34) . Release from calnexin
coincides with protein folding and oligomer assembly, sug-
gesting that calnexin acts as an ER chaperone. Different
protein features have been described to be critical for asso-
ciation with calnexin. Some studies propose that calnexin
interaction with newly synthesized proteins is mediated via
the transmembrane region (35), whereas other reports sug-
gest a specific role for N-linked glycans (36). Hammond
and colleagues (37) have provided evidence that glucose
residues on partially trimmed core glycans makes a critical
contribution to the interaction between nascent protein
chains and calnexin. In these studies protein folding, glu-
cose removal, and release from calnexin coincide. Concor-
dant data on an important role for N-linked glycans in cal-
nexin binding have recently been reported for TCR-a
chains (38) and MHC class I molecules (39, 40) . In con-
trast, the CD3e subunit of the TCR complex, which binds
strongly to human calnexin in the absence of other recep-
tor polypeptides (41), lacks N-linked glycans. For this latter
integral protein, Rajagopalan et al. (41) have suggested that
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the association with calnexin is regulated by the oligomeric
state of the TCR complex. Arunachalam and Cresswell
(42) have also recently reported that human class II and Ii
chains produced in cells treated with tunicamycin, an in-
hibitor of core glycan addition, still show association with
calnexin.
The notion of calnexin as a chaperone showing pro-
longed interactions with incompletely folded proteins would
be in accord with the ER retention of class II and Ii pro-
duced independently of one another, with their association
with calnexin shortly aftersynthesis, and with their efficient
release from the ER being related to the loss ofthis associa-
tion upon formation of a properly assembled nonamer (31,
32) . Such a model of calnexin as a chaperone involved in
actively promoting class I1-Ii subunit folding and/or associ-
ation might predict that in the absence of its binding to one
or more of these chains, the generation of properly folded
oligomers would be inhibited or prevented. Our recent
analysis of Ii structure and function revealed, however, that
a truncated form of mouse invariant chain (residues 1-107)
was quite efficient in assembling with class 11 and promot-
ing ER to Golgi transport (43). Because this segment of Ii
lacked both N-linked glycans as well as most of the lume-
nal domain of Ii, it was possible that it failed to associate
with calnexin, which, if true, would argue against a neces-
sary role of the latter in these aspects of Ii function.
To explore this question further, we have directly exam-
ined the interactions of normal and mutant mouse Ii chains
with calnexin and explored the role of N-linked glycans in
this association. Our data reveal that such glycans play an
important but not exclusive role in regulating Ii-calnexin
interaction, and that Ii-calnexin association is not essential
for class 11-Ii assembly or transport. Rather, a major func-
tion of calnexin seems to be the retention of Ii in the ER
and the inhibition of degradation of this retained protein.
Both of these features promote effective class 11-1i assembly
while protecting the cell from the untoward consequences
of free Ii in the endocytic pathway (7, 44, 45).
Materials and Methods
Plasmid Construction.
￿
cDNA expression vectors containing in-
serts coding for wild-type mouse (m) 101, mlil9-215, mlil-107,
and mli19-107 have been previously described (18, 43) . A cDNA
expression construct containing IP90 (46) was kindly provided by
Dr. M. B. Brenner (Harvard Medical School, Boston, MA) .
A DNA fragment containing mlil-131, 5' translation control
elements, and EcoRl, BamHI, and HindIIl cloning sites was gen-
erated by PCR amplification as previously described (43) . pcEXV-
3mli31 was used as template, and the following oligonucleotide
primers were used: upstream 5'000AATTCAAGCTTACTA-
GAGGCTAGAGCCATG 3' and downstream 5'AAGAATTCG-
GATCCCTATTACCTCGTGAGCAGATGCATCAC3' . The
amplified fragment was digested with EcoRI and inserted into the
EcoRI cloning site in the cDNA expressionvector pcEXV-3 (18).
A clone with the insert in the proper transcriptional orientation
was selected for use. The wild-type and mutant Ii molecules stud-
ied here are shown schematically in Fig. 1 .
Transient Expression.
￿
A modified DEAE-dextran procedure
was used as previously described to transiently transfect COS 7 .2cells (7) . After two washes with DME containing 10 mM Hepes,
COS cells were incubated with DME/10 mM Hepes containing
400 Rg/ml DEAE-dextran, 100 ft,M chloroquine, andDNA (1
lt,g ofeach plasmid) . After4 h at 37°C, the cells were treated with
10%DMSO in PBS for 2 min at room temperature and then in-
cubated in complete medium . 48 h after transfection the cells
were used for labeling and immunoprecipitation .
Metabolic Radiolabeling, Immunoprecipitation, and SDS-PAGE
Analysis . Transfected COS cells were incubated for 1 h in me-
thionine- and cysteine-free medium . 15S-TRANS label (methio-
nine and cysteine) (500 lt,Ci/ml) was then added and the cells in-
cubated for the indicated time (from 5 to 30 min) . Some samples
were lysed immediately (pulse) either in 1% NP-40 or in 0.3%
CHAPS . Other labeled cell samples were incubated for an addi-
tional 15 min or 2 hin medium containing an excess of cold me-
thionine and cysteine (chase), then lysed as indicated . Where in-
dicated, chloroquine (100 It,M; Sigma Chemical Co ., St . Louis,
MO) and/or tunicamycin (10 Wg/ml; Sigma Chemical Co .) were
added to the culture medium during the prelabeling step and
were maintained at these concentrations during pulse-labeling
and chase incubations . Brefeldin A (5 NLg/ml ; Epicentre Technol-
ogies, Madison, WI) was added to appropriate samples during the
chase only . The precleared lysates were immunoprecipitated us-
ing mAbs previously bound to protein G-Sepharose beads, as
previously described (43) . Treatment of immunoprecipitated pro-
teins with endoglycosidase H was as described (43) . For tunica-
mycin-treated CBA spleen cells, additional preclearing steps were
performed using Con A-Sepharose beads. The eluted samples
were analyzed by SDS-PAGE in reducing conditions . In the
cross-linking experiment, 200 l.tg/ml of the water-soluble, re-
ducible cross-linking reagent dithiobis[succinimidylproprionate]
(DSP ; Pierce Chemical Co ., Rockford, IL) were added to the
lysing buffer.
Results
Relationship between Ii Glycosylation and Calnexin Binding .
Hammond et al . (37) have proposed that glucose residues
on partially trimmed N-linked glycans play a critical role in
2029
￿
Romagnoli and Germain
regulating calnexin interaction with membrane glycopro-
teins in the ER, and this hypothesis is well supported by
several recent studies (38-40) . Nevertheless, some pub-
lished data argue that such carbohydrate residues are not
absolutely required for calnexin binding, including work
with human Ii (42) . Fig . 2 shows that 4.5 h after synthesis, a
greater fraction of the carbohydrates of class II molecules
associated with a truncated form ofmouse invariant chain
lacking the normal N-glycosylation sites (mlil9-107) are
resistant to endoglycosidase H digestion than those on ei-
ther class II expressed in the absence of Ii or expressed in
the presence of invariant chain lacking only a segment of
the cytoplasmic tail (mlil9-215) . These data are consistent
with highly efficient export from the ER to the Golgi
complex of the class II molecules associated with truncated
li lacking N-glycosylation sites, a finding that might indi-
cate a loss of calnexin-mediated retention of li, as well as
the absence of a requirement for li-calnexin association
during assembly and traffickingofli-class II complexes . We
therefore undertook to directly examine whether the two
N-linked carbohydrates on mouse Ii contributed to the in-
teraction of this molecule with calnexin . Two different ap-
proaches were used: drug inhibition of N-glycosylation
(tunicamycin) and the study of deletion mutants of the lu-
menal region of li, some of which lacked the residues at
which N-glycosylation normally occurs .
Proteins from lysates of pulse-labeled COS cells coex-
pressing intact mli31 and human calnexin (IP90) were im-
munoprecipitated with anti-invariant chain (IN-1 ; 47) or
anti-human calnexin (AF-8 ; 46) mAbs . AF-8 immunopre-
cipitates showed a distinct band of coprecipitating mli31
(Fig. 3 A) . The AF-8 mAb does not bind to the endoge-
nous simian calnexin present at high concentration in the
ER of the COS cells . Therefore, the amount of mli copre-
cipitated with human calnexin by this mAb is likely to sig-
nificantly underestimate the actual level of association of Ii
with the total calnexin pool . Similarly, only a modest
Figure 1 .
￿
Schematic representation of wild-
type mouse 101 and truncated forms of Ii used
in this study . The striped boxes represent the Ii
transmembrane region . Shaded boxes indicate Ii
N-linked glycosylation sites . Numbering refers
to amino acid positions in the protein. IN-1
and P4H5 mAb binding regions are indicated .
NNH Z ternunus of protein ; COOH, COOH
terminus of protein .Figure 2 .
￿
The N-linked glycan-free truncation mutant mlil9-107 as-
sembled with class II shows enhanced ER to Golgi transport. COS cells
expressing the class II chains Aab and Apb alone or together with either
mli19-215 or mlil9-107 were metabolically labeled (30 min), then
chased for 4 h . Detergent lysates were immunoprecipitated with Y3P
(anti-Ab mAb), treated with endoglycosidase-H (+), then analyzed by
SDS-PAGE and autoradiography. A13s indicates the position ofA(3 chains
with endoglycosidase H-sensitive glycans ; Aar indicates the position of
Ant chains with endoglycosidase H-resistant glycans .
amount oflabeled calnexin is seen in the reciprocal immu-
noprecipitation with IN-1, due to a large pool of preexist-
ing endogenous calnexin in these transfected cells that does
not label under these conditions, and that competes with
the newly synthesized, labeled human protein for binding
to Ii .
Tunicamycin treatment of transfected COS cells, which
inhibited most but not all the addition of core glycans to
the overproduced nascent Ii protein chains, resulted in the
coprecipitation of little or no nonglycosylated mIi31 with
calnexin (Fig . 3 B), consistent with several reports on the
importance of N-linked oligosaccharide in nascent protein
interactions with calnexin (36-40), but in distinction to the
data of Arunachalam and Cresswell (42) . We then analyzed
the association of deletion mutants of Ii with calnexin . As
shown in Fig . 3, C and D, neither mli1-107 nor mli1-131
coprecipitated with calnexin .
Given the results obtained with tunicamycin and m1i31,
it was surprising to find that mlil-131, which contains both
of the N-glycosylation sites ofmli31 and is extensively gly-
cosylated in COS cells, did not show detectable association
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with calnexin under these conditions . These results suggest
that the sugar moieties alone, while perhaps necessary, are
not sufficient for tight binding of Ii to the chaperone . To
examine whether the failure to observe calnexin-mlil-131
interaction under our standard cell lysis conditions reflected
a weak but perhaps physiologically significant association
between these molecules, pulse-labeled COS cells express-
ing human calnexin and either mlil-131 or mlil-107 were
lysed in the presence of the reduction-sensitive cross-link-
ing agent DSP . As shown in Fig. 4, reduction after immu-
noprecipitation with AF-8 demonstrated that mlil-131
was associated with calnexin at the time of cell lysis,
whereas mlil-107 was not. Thus, the presence ofN-linked
carbohydrates on a molecule lacking the complete lumenal
portion of Ii (mIil-131) is sufficient for a less stable interac-
tion with calnexin, whereas the absence of both the sugars
and the COOH-terminal segment of Ii (mlil-107) leads to
a lack of any detectable association . These latter results, to-
gether with the data shown in Fig . 2 on the effective as-
sembly of class 11 with mli19-107, also indicate that Ii in-
teraction with calnexin is not required for the formation of
class II-Ii complexes .
Immunoprecipitation experiments using COS cells syn-
thesizing class II ot and (3, mli31, and human calnexin in
the presence of tunicamycin confirmed the ability ofclass II
to associate with Ii in the absence of detectable calnexin
binding (data not shown) .
Elimination of Calnexin Association Promotes Ii Degradation
in a Preendosomal Compartment ofCOS Cells . Many pro-
teins that are part of oligomeric assemblies are rapidly de-
graded in the absence of their partner chains or interaction
with resident chaperones . It was thus ofinterest to examine
whether the virtual elimination of Ii-calnexin interactions
in cells lacking class II affected the stability of Ii that had
not reached it usual site of degradation in endosomes/lyso-
somes . To accomplish this, we examined the extent ofdeg-
radation of wild-type Ii and Ii mutants by performing
pulse-chase experiments in the presence of chloroquine
Figure 3 .
￿
Relationship between Ii gly-
cosylation and calnexin interaction . (A
and B) COS cells expressing IP90 plus
mIi31 were metabolically labeled (30 min)
in the absence (A) or presence (B) oftuni-
camycin . CHAPS lysates were inununo-
precipitated with an anti-Ii mAb (IN-1)
or an anti-calnexin mAb (AF-8) . The
eluted boiled samples were analyzed by
SDS-PAGE . Arrows on the right of the
figure indicate the migration of IP90 and
the different glycosylation forms of mli31
(numbers o£ carbohydrates shown in pa-
rentheses) . (C and D) Pulse-labeled lysates
of COS cells expressing either IP90 plus
mIil-131 (C) or IP90 plus mlil-107 (D)
were immunoprecipitated with an anti-Ii
mAb (IN-1) or an anti-calnexin mAb
(AF-8) . The boiled eluted samples were
analyzed by 10 and 12% SDS-PAGE, re-
spectively . Arrows on the right ofthe fig-
ure indicate the migration of IP90, mli1-
131, and mlil-107 .Figure 4 . mlil-131, but not
mlil-107, associates with cal-
nexin . COS cells expressing ei-
ther IP90 plus mIil-107 or IP90
plus mlil-131 were metaboli-
cally labeled (30 min) and lysed
in CHAPS in the presence of a
cross-linking agent, DSP . An
anti-li mAb (IN-1) or an anti-
calnexin mAb (AF-8) was used
in immunoprecipitation . The
boiled eluted samples were ana-
lyzed under reducing conditions
by 12% SDS-PAGE . Arrows on
the right of the figure indicate
the migration ofIP90, mlil-131,
and mlil-107 .
and/or brefeldin A, to minimize any proteolysis ofIi in the
endocytic pathway .
Such studies in COS cells expressing either mli31 or
mlil-107 showed different degrees of stability of these two
forms of Ii . The wild-type protein mli31 was found to be
stable during the time frame of our experiments, as shown
by the quantitative recovery ofpulse-labeled molecules af-
ter a 2-h chase (Fig. 5 A) . mlil-107 was much more sus-
ceptible to preendosomal degradation under the same con-
ditions, with 50% loss of signal during this same time
period (Fig. 5 C . Additional experiments showed that 75-
80% of this form of Ii was degraded by 4 h, whereas mIi31
was largely intact at this time (data not shown) . These data
indicate a half-life for mlil-107 of -2 h under these con-
ditions in transiently transfected COS cells producing large
amounts of this protein .
Given that wild-type mIi31 shows clear binding to cal-
nexin whereas the truncation mutant mlil-107 does not,
these results are consistent with the hypothesis that calnexin
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binding promotes the stability ofnewly synthesized invari-
ant chains, just as calnexin-TCR-a chain association pro-
tects the latter from rapid prelysosomal destruction (38) .
This model would predict that tunicamycin should affect
the rate of degradation of wild-type mIi31 and of mli1-
131, but not the glycan-free mlil-107 . As expected, mIi31
became sensitive to degradation when synthesized in cells
cultured in tunicamycin (Fig. 5 A) . In agreement with the
cross-linking data showing calnexin-mIil-131 association,
the fate ofmliI-131 was also dramatically influencedby the
presence of tunicamycin, with only 50-60% of the initial
pool of labeled molecules remaining after the chase (Fig . 5
B), whereas loss of mlil-107 occurred at the same rate in
the presence and absence of tunicamycin (Fig. 5 C . These
data are in clear accord with the view that calnexin associa-
tion plays a critical role in protecting li from nonendocytic
proteolysis .
Effects of Preventing Ii-Calnexin Interaction in Lymphoid Cells
Normally Synthesizing Class II and Ii . All the experiments
described above were performed using transient overex-
pression in heterologous fibroblasts . Although our previous
experience indicated that many properties of class II and Ii
in these cells resembles that in lymphoid cells, some aspects
of class II-Ii assembly and transport differ in the fibroblast
and physiologic APC models . Therefore, to determine
whether our observations concerning a role for calnexin in
regulating preendosomal li degradation reflect what hap-
pens in "professional" APC, we examined the effect of tu-
nicamycin on li degradation in freshly isolated lymphoid
cells . CBA spleen cells were pulse labeled for 5 min and
chased for 15 min in the presence or absence of tunicamy-
cin . l i immunoprecipitates were then analyzed by SDS-
PAGE, autoradiography, and densitometry . In the absence
of tunicamycin, mli31 in these cultured spleen cells
showed no significant degradation during this brief chase
period . In contrast, only 60% of the initially labeled pool of
mIi31 remained after 15 min of chase in cells treated with
tunicamycin to prevent glycan addition and interfere with
Figure 5 .
￿
Extensive preendocytic
degradation as a result of the inhibi-
tion of Ii-calnexin interaction .
COS cells expressing mli31 (A),
mlil-131 (B), or mlil-107 (C) were
pulse labeled (30 min; p) and chased
(2 h ; c) in the presence or absence of
tunicamycin (T) . In addition, chlo-
roquine (Ch) and/or brefeldin A (B)
was added to the indicated samples .
Lysates were immunoprecipitated
with an anti-Ii mAb (IN-1) . The
boiled eluted samples were analyzed
by 12% SDS-PAGE . Arrows on the
right o£ the figure indicate the mi-
gration of mh31, mlil-131, and
mlil-107, and the labels in paren-
theses indicate the number of
N-linked glycans on each. The
numbers below each lane give the
chase/pulse intensity ratio as a per-
centage, as determined by densito-
metric analysis.Figure 6 .
￿
The inhibition of Ii-calnexin interaction using tunicamycin
promotes rapid Ii degradation but does not prevent assembly ofthe a/13 Ii
complexes in normal cells . Spleen cells from CBA mice were pulse la-
beled for 5 min and then chased for 15 min in the absence (left) or pres-
ence (right) of tunicamycin . Tunicamycin-treated lysates were precleared
with Con A-Sepharose beads. An anti-Ii mAb (IN-1) or an anti-MHC
class I mAb (10.2.16) was used in immunoprecipitations . Immunoprecip-
itates were separated by 12% SDS-PAGE . The numbers below each lane
give the chase/pulse intensity ratios as a percentage, as determined by
densitometric analysis . mlip4l refers to the form ofmli containing the al-
ternatively spliced exon 66 .
calnexin association (Fig . 6), suggesting an even more rapid
loss of Ii in the putative absence of calnexin binding than
was seen in the COS system .
We also examined the association of Ii with class II un-
der these conditions. MHC class 11-associated Ii and total Ii
were quantified by densitometry from 10.2.16 and IN-1
immunoprecipitates, respectively . The ratio of Ii in the
10.2.16 versus IN-1 precipitates, which indicates the pro-
portion of the total Ii pool that is complexed with aR het-
erodimers, decreased from 3.8 to 2 in the presence oftuni-
camycin . Total protein synthesis, including class II, was,
however also decreased nearly 50% in the treated cells, so
correcting for the smaller class II pool subject to 10.2 .16
precipitation, these data indicate that a treatment expected
to eliminate Ii-calnexin association has little effect on the
initial extent of Ii-class II assembly . These data are consis-
tent with the results shown in Fig. 2 concerning effective
assembly of class II with the truncation-mutant mlil9-107
and experiments using tunicamycin-treated COS cells co-
expressing class II, intact Ii, and human calnexin (data not
shown) .
Discussion
Ii and class II are among the large number of integral
membrane proteins known to associate with the ER resi-
dent protein calnexin shortly after synthesis (31, 32) . These
associations are not efficiently disrupted until the complete
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nonameric complex of three class II up heterodimers on a
trimeric core of Ii is formed, after which rapid exit of this
complex from the ER can be detected . These data suggest
that calnexin might play an important role in facilitating
the assembly of the class II-Ii oligomer, in addition to re-
taining the component chains in the ER until proper coas-
sembly is complete . These studies did not reveal, however,
the fate of either class II or li in the absence of such cal-
nexin binding . Studies in other model systems have impli-
cated calnexin as a chaperone involved in the folding path-
way for both soluble (48-50) and membrane-bound (37)
proteins, whereas other investigations have provided evi-
dence for calnexin acting primarily as a retention protein,
regulating release of otherwise properly folded but incom-
pletely assembled subunits of oligomeric proteins from the
ER (41, 51) . Studies of both TCR-et chains (38) and
MHC class I heavy chains (39, 40), have also indicated that
at least some component chains of oligomeric protein as-
semblies are rapidly degraded in the absence of such cal-
nexin binding .
Our previous studies of Ii mutants lacking portions of
the lumenal domain raised a question about the need for
calnexin binding in the function of Ii . Two truncated
forms of Ii encompassing residues 1-107 or 19-107 lacked
sites for addition of the N-linked glycans shown for some
other proteins to be essential for association with calnexin,
but nevertheless were very effective in performing the
secretory pathway functions of Ii, which include assembly
with class II a and R chains, enhanced formation of prop-
erly assembled a(3 heterodimers, prevention of aggregation
ofclass II chains with each other and/or other ER proteins,
and efficient transport of class II dimers through the Golgi
complex (43) . We thus chose to examine the role ofN-linked
ycans in the interaction of calnexin with the invariant
chain, and upon finding differential association of this
chaperone with distinct forms of Ii, to assess the impact of
a lack of calnexin-li binding on li assembly and assembly
with class 11 .
Two different approaches were used: either treatment of
cells with tunicamycin, an inhibitor of core oligosaccharide
addition, or expression of a truncated form of li lacking the
sites for addition of N-linked carbohydrate . Most or all
measurable calnexin interaction with li was lost in the ab-
sence ofsuch N-linked glycans, in agreement with the work
of several investigators in other model systems (37-40) but
in contrast to recent studies using human Ii (42) . The dif-
ferences between our experiments and this prior investiga-
tion cannot be readily ascribed to the use of distinct deter-
gents for cell solubilization, as we have observed the same
results reported here with either CHAPS or digitonin (Ro-
magnoli, P ., unpublished observations) . Despite the high
level of conservation of Ii structure during evolution, spe-
cies differences remain a possible explanation for these ap-
parently discrepant findings, especially given the existence
of alternative forms of Ii produced by human (52) but not
mouse cells . These forms have unique ER retention prop-
erties (53) that might supplant those of calnexin . This in
turn could lead to a distinct physiology of interaction be-tween Ii and this chaperone. Alternatively, the association
ofhuman calnexin with mouse Ii might be weaker than for
the human-human combination.
Our experiments have also revealed that the strength of
interaction of calnexin with Ii is not determined solely by
these oligosaccharides. Detection ofcalnexin binding to the
mlil-131 truncation mutant by immunoprecipitation re-
quired chemical cross-linking, despite the addition of
N-linked glycans to this form of Ii. Thus, protein structural
features, in this case controlled by the COOH-terminal In-
menal region of the invariant chain, either affect calnexin-
carbohydrate interaction or, independently from the sugars,
promote association with calnexin. Such an ability of pro-
tein structure to directly regulate calnexin binding is in ex-
cellent agreement with observations that some secreted or
membrane proteins lacking N-linked glycans nevertheless
interact strongly with calnexin (41), with other data on a
role for glucose-containing N-linked glycans in initiating
but not maintaining calnexin-protein interactions (39, 40),
and evidence that for some secretory proteins, such as thy-
roglobulin undergoing disulfide maturation, the redox state
of the protein seems to regulate calnexin interaction (50).
Human and mouse Ii may differ in the degree to which this
protein structure-dependent binding to (human) calnexin
can take place in the absence of a glycan-driven initiating
event, perhaps explaining the differences between this study
and that ofArunachalam and Cresswell (42).
Ii is a very proteolytically sensitive protein (54-56), a
property that is central to its function as a type of propiece
or "disposable chaperone" for class II molecules. Cathepsin-
mediated proteolytic cleavages in the endocytic pathway
(57) sequentially remove (7) structurally discrete regions of
Ii (57a) . This process eventually exposes a functional class
II-binding site (7, 43, 58) able to interact with denatured
and/or degraded protein antigens in endocytic locations.
Recent in vitro studies have demonstrated that the CLIP
segment of Ii (59) that is critical to Ii-class II interactions
(43, 60, 61) is especially sensitive to proteases when Ii is not
bound to class II (57a, 62) . In contrast to these in vitro re-
sults, Ii has been shown to be quite stable in the ER ofliv-
ing cells (1, 30). This makes physiologic sense, as it is essen-
tial that newly synthesized Ii in the ER remain intact in the
CLIP region if it is to properly associate with class II and
carry out its various preendocytic functions. The present
study shows that several distinct maneuvers (tunicamycin
treatment, truncation) that share the property of inhibiting
Ii-calnexin association result in enhanced secretory path-
way degradation of Ii. The rate of degradation was ex-
tremely fast in normal spleen cells (t1,2 of -15 min) com-
pared with COS cells (t1,2 of 2 h). In the latter cells, very
high level synthesis of this protein may saturate the pro-
teolytic machinery, decreasing the effective degradation
rate. These data imply that Ii is inherently susceptible to
proteolytic attack when unbound to either calnexin or class
II . A primary function of Ii association with calnexin may
therefore be to protect the large pool of free Ii from such
destruction, so that it can serve to efficiently interact with
the entire cohort of newly synthesized class II .
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Could the increased rate of degradation be an artifact
arising from protein misfolding due to either absence of
N-linked glycans on Ii produced in the presence of tunica-
mycin, or misfolding due to the removal of the bulk ofthe
COOH-terminal segment of Ii in the case of mlil-107?
The similar extent of degradation of both full-length and
shorter forms of Ii, together with the recent structural data
(57a) supporting our model that the lumenal regin of Ii has
two discrete domains (43), argue against this possibility. It is
also inconsistent with our previous (43) and current dem-
onstration that mlil-107 or mli19-107 rapidly and effi-
ciently associate with coexpressed class II and effectively
promote its egress from the ER compartment, functions
that should not occur if these forms of Ii were substantially
misfolded. Finally, experiments reported here using both
transfected COS cells and normal spleen cells also show
that initial assembly of intact Ii with class II is not substan-
tially affected in cells producing Ii in the presence of tuni-
camycin, which in the COS model could be directly
shown to prevent calnexin association. It thus seems more
likely that calnexin association protects intrinsically sensi-
tive sites of properly conformed, non-class II-associated Ii
from protease attack than that this molecule helps fold Ii
into a protease-resistant structure.
We and others have also shown that the production of
high levels of Ii, especially in the absence of class II coex-
pression, leads to disturbances in the structure and function
of early endosomal compartments (7, 44, 45) . Cells ex-
pressing substantial amounts of free, full-length Ii show
characteristic enlarged early endosomes and a delay in en-
docytic trafficking from these early compartments to late
endosomes/lysosomes (7, 63) . It is difficult to produce sta-
bly transfected cells with high free-Ii levels, apparently due
to these endocytic disturbances (unpublished observations) .
Although milder alterations in endosomal function may be
a physiologically relevant effect of Ii that helps coordinate
the flow of antigen and class II-Ii complexes in APC (7,
63), excess movement of Ii from the secretory pathway to
the endocytic pathway is clearly undesirable. Calnexin as-
sociation would be expected to retain Ii in the ER, limiting
these deleterious effects of high levels of Ii expression. In
accord with this possibility, the data in Fig. 2 and our prior
work (43) indicate that mlil-107 or mlil9-107, which are
not tightly associated with calnexin, leave the ER more
rapidly than mIi31, which is bound to this chaperone. Thus,
by stabilizing associated Ii and simultaneously retaining it in
the ER, calnexin allows the attainment of the high molar
ratios of Ii to class II necessary to ensure that Ii and not
other ER ligands interact with newly synthesized class II
binding sites while preventing this accumulation of free Ii
from adversely affecting cell survival.
Although roles for calnexin can thus be found in the pre-
vention of Ii degradation and in Ii retention, we were un-
able to discern a necessary contribution of calnexin to ef-
fective assembly of Ii with MHC class II molecules. This
was true of mlil-107 or mlil9-107 in COS cells, intact Ii
in tunicamycin-treated COS transfectants, and mIi31 in
normal spleen cells. Analysis of Ii and associated AoLkARkbehavior at later times in the spleen cells was complicated
by the very rapid loss of li under tunicamycin treatment
conditions, so that less labeled li was available for contin-
ued assembly or coexport with class 11 . Taken together,
these data seem most consistent with calnexin playing a fa-
cilitating, but not essential, role in the contribution of li to
control of class 11 assembly and transport in the secretory
pathway . Thelack ofan absolute role may arise from redun-
dancy in the function of variousER chaperones . Alterna-
tively, calnexin might play a quantitative role that optimizes
the function of proteins produced at a given biosynthetic
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